Drug Type Hormone |
Synonyms 3',3,5-Triiodothyroacetic acid, Emcitate, Teatrois + [6] |
Target |
Mechanism THR-α agonists(Thyroid hormone receptor alpha agonists), THR-β agonists(Thyroid hormone receptor beta-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationFast Track (US), Orphan Drug (US), Rare Pediatric Disease (US), Orphan Drug (EU) |
Molecular FormulaC14H9I3O4 |
InChIKeyUOWZUVNAGUAEQC-UHFFFAOYSA-N |
CAS Registry51-24-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07214 | Tiratricol |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allan-Herndon-Dudley Syndrome | NDA/BLA | - | - |
NCT02060474 (Pubmed) Manual | Phase 2 | 46 | Triac | mngokuzbbe(vuqiahlyzx) = (transiently increased perspiration or irritability) occurred in six (13%) patients wogosjdgcq (azracnylrw ) View more | Positive | 01 Sep 2019 |